| Spirig HealthCare AG - Linagliptin Metformin Spirig HC 2,5 / 850 mg, Filmtabletten | | 70591 | | 02 | | Linagliptin Metformin Spirig HC 2,5 / 850 mg | | Filmtabletten | | A10BD11 | | Metformin and Linagliptin | | 24.06.2026 | | |
| | Composition | | linagliptinum 2.5 mg, metformini hydrochloridum 850 mg, copovidonum K 28, maydis amylum, natrii carbonas, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, E 171, talcum, propylenglycolum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 7.81 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Linagliptinum | 2.5 mg | | Metformine Hydrochloride | 850 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Copovidonum K | 28 | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Maydis Amylum | | | | Sodium Carbonate | | | | Pro Compresso Obducto | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 60 | | | B | | Oui | | 004 | 180 | | | B | | Oui |
|
|
